Mon, Mar 2, 2015, 2:16 PM EST - U.S. Markets close in 1 hr 44 mins

Recent

% | $
Quotes you view appear here for quick access.

AVAX Technologies Inc. Message Board

  • possibilties36 possibilties36 May 14, 2012 12:16 PM Flag

    This is why we are going UP

    Up I think.

    New vaccine therapy to treat the deadly chemo-resistant ovarian cancer

    Posted on April 13, 2012 by admin| Leave a comment


    A better hope for thousands of women suffering from the ‘often resistant to chemotherapy’ ovarian cancer at its advanced stage. A new cancer vaccine therapy is on its way to launch expanding treatment options to such women. Thanks to the Cancer Treatment Centers of America. The vaccine is developed by AVAX Technologies, Inc. Dr. Edgar Staren, Chief Medical Officer of Cancer Treatment Centers of America said, Cancer Treatment Centers of America’s number one priority is to help our patients win the battle against cancer. This vaccine therapy represents a promising new chapter in the fight against this devastating disease and brings hope to women everywhere. Interestingly, this treatment method creates a patient-specific vaccine, using the patient’s own tumor tissues. The method also combines chemotherapy delivered directly into the abdominal cavity along with it. Dr. Staren said, To win the fight against cancer, it is absolutely vital we do everything we can to make innovative new treatments like this available to patients as soon as possible. It’s inconceivable that treatments like these – that give hope to patients – are often left on the laboratory bench, while cancer patients are told there is nothing more that can be done for them.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AVXT.PK
0.025+0.015(+150.00%)Oct 31 3:54 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.